"Quinoline binding site on malaria pigment crystal: A rational pathway for antimalaria drug design" by Buller et al. (Publication Summary)

Thank you for your interest in our anti-malarial drug design publication. The paper outlines how researchers at the Weizmann Institute of Science, Israel, and Transform Pharmaceuticals, Cambridge, MA, used crystal morphology-predicting software tools to model the crystal formation of the malaria pigments crystals, the by-products of hemoglobin digestion by the malaria parasite, and used this information to propose binding sites for quinoline-based anti-malarial drugs.

* This publication is available only in hardcopy format due to the publisher's distribution laws.

In order to receive a complimentary copy of this paper, please fill out the form below:

Contact Information

First Name*
(Required)
Last Name*
(Required)
Organization*
(Required)
Organization Type*
(Required)
Address 1*
(Required)
Address 2
(Required)
City*
(Required)
State/Province (US/Canada only)*
(Required)
State/Province (other)
(Required)
Zip/Postal Code*
(Required)
Country*
(Required)
Phone*
Required: a valid telephone number (no letters)
Fax
Required: a valid telephone number (no letters)
Email*
Required: a valid email address

Disclaimer

Accelrys will store the data you have provided in a database which is accessible by appropriate personnel who have a business need for the information. For full details on our privacy policy please see http://accelrys.com/company/legal/

Accelrys may contact me by e-mail with updates and information on products or services

Accelrys may share the information I have provided with its strategic partners, who may contact me about related products or services

Careers | Legal / Terms of Use | Contact us